UltragenyxEigentümerstruktur
| Preis (2026-07-24) | 52W Hoch | 52W Tief |
| 26.9 USD | 39,89 USD | 18,29 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 53,368 USD | 13 | 6 | 1 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 98.489.224 | 17,03 | 5,36 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Ultragenyx
Mitarbeiter 1.371
Handelsplatz NASDAQ
Ticker Symbol RARE
IPO Datum 2014-01-31
Adresse 60 Leveroni Court, Novato, CA, United States, 94949
Webseite https://www.ultragenyx.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Emil D. Kakkis M.D., Ph.D. | Founder, President, CEO & Director |
| 2 | Mr. Howard Horn | Executive VP of Corporate Strategy & CFO |
| 3 | Ms. Karah Herdman Parschauer J.D. | Chief Legal Officer & Executive VP of Corporate Affairs |
| 4 | Mr. Erik Harris M.B.A. | Executive VP & Chief Commercial Officer |
| 5 | Dr. Eric Crombez M.D. | Chief Medical Officer & Executive VP |
| 6 | Mr. Theodore A. Huizenga | Senior VP, Corporate Controller & Principal Accounting Officer |
| 7 | Mr. Ernie W. Meyer | Chief Human Resources Officer & Executive VP |
| 8 | Mr. Vimal Srivastava | Senior Vice President of Business Development & Alliance Management |
| 9 | Mr. Dennis Karl Huang | Chief Technical Operations Officer and Executive VP of Gene Therapy Operations |
| 10 | Mr. John Richard Pinion II | Chief Quality Operations Officer & Executive VP of Translational Sciences |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 2 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 3 | Vanguard Portfolio Management, LLC | 0,00% | 0,00 Mio. USD |
| 4 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 5 | AQR Capital Management LLC | 0,00% | 0,00 Mio. USD |
| 6 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 7 | RTW INVESTMENTS, LLC | 0,00% | 0,00 Mio. USD |
| 8 | Sands Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 9 | Sofinnova Ventures | 0,00% | 0,00 Mio. USD |
| 10 | Wellington Management Company LLP | 0,00% | 0,00 Mio. USD |
| 11 | Bellevue Group AG | 0,00% | 0,00 Mio. USD |
| 12 | Two Sigma Investments LLC | 0,00% | 0,00 Mio. USD |
| 13 | Frontier Capital Management CO Inc | 0,00% | 0,00 Mio. USD |
| 14 | Citadel Advisors Llc | 0,00% | 0,00 Mio. USD |
| 15 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 16 | Millennium Management LLC | 0,00% | 0,00 Mio. USD |
| 17 | GW&K Investment Management, LLC | 0,00% | 0,00 Mio. USD |
| 18 | Morgan Stanley - Brokerage Accounts | 0,00% | 0,00 Mio. USD |
| 19 | Jacobs Levy Equity Management, Inc. | 0,00% | 0,00 Mio. USD |
| 20 | VOLORIDGE INVESTMENT MANAGEMENT, LLC | 0,00% | 0,00 Mio. USD |